Nan Jin Chunxiao Sun Yijia Hua Xinyu Wu Wei Li Yongmei Yin
10.3389/fonc.2022.859157
Front Oncol
2022 Apr 27;12:859157.
anlotinib anti-angiogenesis case report hemangioblastoma tyrosine kinase inhibitor (tki)
CC BY
https://pubmed.ncbi.nlm.nih.gov/35574394/
Case Reports
PMC9092942
35574394
Anlotinib for the Treatment of Multiple Recurrent Lumbar and Sacral Cord Hemangioblastomas: A Case Report
2022